Awards
Good Manufacturing Practice: GMP
Thai Meiji Pharmaceutical Co., Ltd.
Thai Meiji Pharmaceutical Co., Ltd.
A Legacy of Trust: Part of the Meiji Group
We are a proud member of the Meiji Group—a globally trusted Japanese enterprise with over 100 years of excellence in food and pharmaceutical innovation. From nutrition to lifestyle, and prevention to medicine, we help people of all ages live life to the full.
Our Pharmaceutical Heritage
Since our landmark success in pioneering antibiotic innovation in 1946, Meiji Seika Pharma Co., Ltd. has remained steadfast in its commitment to global health. We provide a diverse portfolio of high-quality pharmaceutical products, including life-saving vaccines, infectious disease treatments, and specialized therapeutics designed to meet evolving medical needs worldwide.
Thai Meiji Pharmaceutical: Excellence in Thailand
To bring this global expertise to the region, Thai Meiji Pharmaceutical Co., Ltd. was established on November 1, 1979, at the Ladkrabang Industrial Estate as a strategic joint venture between Thai and Japanese partners.
As a leader in local manufacturing, we were the first plant in Thailand to implement a fully integrated production system—seamlessly managing the entire process from Active Pharmaceutical Ingredients (API) to finished products. By leveraging state-of-the-art Japanese technology, we are dedicated to delivering world-class pharmaceutical solutions to both domestic and international markets.
Awards
Good Manufacturing Practice: GMP
Meiji Group’s mission is to widen the world of “Tastiness and Enjoyment” and meet all expectations regarding “Health and Reassurance”.
Our wish is to be closely in tune with our customers’ feelings and to always be there to brighten their daily lives.
Our responsibility as “Food and Health” professionals is to continue finding innovative ways to meet our customers’ needs, today and tomorrow.
In order to be an essential part of our customers, partners, and colleagues’ daily lives, we must;
Listen to and learn from our customers
Find ways to identify tomorrow’s trends and be prepared to led the way
Make our work exciting, and create exciting work
Have the strength and courage to confront any issue, rather than to avoid them
Always believe in our team’s potential, and make the most of its abilities
Through utilizing Japanese technology and the effort of all employees, today Thai Meiji Pharmaceutical Company Limited is ever committed to improve the efficiency of the manufacture of pharmaceuticals as well as the development of new products to serve both domestic and export markets.
Another important factor for the company is its policy to expand its manufacturing base to meet the demands of domestic and international consumers for internationally standardized pharmaceuticals.
Apart from its pharmaceutical business, Thai Meiji Pharmaceutical Company Limited is committed towards social responsibility and organizes various social projects such as fund raising, donations to charities, support to medical services, and blood donations for the Thai Red Cross Society.
Thai Meiji Pharmaceutical Company Limited will always strive to develop and continue to move forward to create the highest quality pharmaceuticals and veterinary products, hand in hand with Thai society to serve the entire world.
The company firmly believes that the quality of society is the responsibility of its members.
Since its establishment, Thai Meiji Pharmaceutical Company Limited has always been committed to the supply of the quality pharmaceutical and veterinary products with the development of manufacturing technology, using the highest quality raw materials and state-of-the-art machinery, supervised by expert personnel.
Since its pioneering launch of penicillin in 1946, Meiji Seika Pharma Co., Ltd. has remained steadfast in its commitment to global health. We provide a diverse portfolio of high-quality, efficacious pharmaceuticals, including essential vaccines, infectious disease treatments, central nervous system (CNS) therapeutics, and reliable generic medicines.
Driven by innovation and Japanese precision, we continue to evolve our clinical expertise to meet the ever-changing medical needs of patients worldwide.
For more information, please
